| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.01B | +19.2% |
| Cost of Revenue | $535.3M | +26.1% |
| Gross Profit | $1.47B | +16.9% |
| R&D Expense | $596.8M | +15.7% |
| SG&A Expense | $219.2M | +13.3% |
| Operating Income | -$216.1M | +7.6% |
| Interest Expense | $8.1M | -13.8% |
| Pre-tax Income | -$131.6M | +19.5% |
| Income Tax | -$2.5M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $490.1M | -39.0% |
| Accounts Receivable | $393.1M | +20.7% |
| Current Assets | $2.92B | +17.7% |
| Total Assets | $3.43B | +19.5% |
| Current Liabilities | $562.0M | -0.4% |
| Total Liabilities | $648.1M | -64.0% |
| Stockholders' Equity | $2.78B | +160.3% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $150.2M | +23.6% |
| Capital Expenditures | $29.6M | +386.5% |
| Investing Cash Flow | -$657.4M | -449.7% |
| Financing Cash Flow | $202.1M | +428.4% |
| Free Cash Flow | $120.6M | +4.5% |
| -119.3% |
| Net Income | -$129.1M | +26.9% |
| EPS (Basic) | -$1.73 | +30.2% |
| EPS (Diluted) | -$1.73 | +30.2% |